UBS Group »

Aclaris Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 20k 1.05
2023-09-30 $354k 52k 6.86
2023-06-30 $29k 2.8k 10.37
2023-03-31 $16k 2.0k 8.09
2022-12-31 $38k 2.4k 15.75
2022-09-30 $43k 2.9k 15.05
2022-06-30 $34k 2.4k 14.13
2022-03-31 $33k 1.7k 19.23
2021-12-31 $672k 46k 14.55
2021-09-30 $30k 1.7k 18.18
2021-06-30 $199k 11k 17.61
2021-03-31 $373k 15k 25.24
2020-12-31 $8.0k 1.3k 6.13
2020-09-30 $13k 5.0k 2.59
2020-06-30 $1.0k 547 1.83
2020-03-31 $20k 19k 1.05
2019-12-31 $71k 38k 1.88
2019-09-30 $10k 9.1k 1.10
2019-06-30 $2.2M 1.0M 2.19
2019-03-31 $4.1M 684k 5.99
2018-12-31 $0 1.3M 0.00
2018-09-30 $0 19 0.00
2018-06-30 $0 19 0.00
2018-03-31 $43k 2.4k 17.51
2017-12-31 $66k 2.7k 24.53
2017-09-30 $156k 6.1k 25.81
2017-06-30 $90k 3.3k 27.34
2017-03-31 $134k 4.5k 29.92
2016-12-31 $75k 2.8k 26.98
2016-09-30 $56k 2.2k 25.53
2016-06-30 $0 941 0.00
2016-03-31 $0 633 0.00
2015-12-31 $2.4k 109 22.22